search URL:,https://patents.google.com/?assignee=NOVACEA+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
AU-2002363959-B2,Pharmaceutical compositions comprising active vitamin D compounds ,"Novacea, Inc.","Andrew-Xian Chen, Jun Fan, Martha J Whitehouse, Xi-Yun Yu",2001-12-03,2002-12-03,2007-12-13,2007-12-13,https://patents.google.com/patent/AU2002363959B2/en,
US-2005101576-A1,Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes ,"Novacea, Inc.","Martha Whitehouse, John Curd",2003-11-06,2004-05-10,2005-05-12,,https://patents.google.com/patent/US20050101576A1/en,https://patentimages.storage.googleapis.com/59/e6/c5/07e503ffe2ea61/US20050101576A1-20050512-D00001.png
US-2006172014-A1,Treatment of lung cancer with active vitamin D compounds in combination with other treatments ,"Novacea, Inc.","John Curd, Martha Whitehouse, Jeffrey Cleland",2003-06-11,2005-12-12,2006-08-03,,https://patents.google.com/patent/US20060172014A1/en,
US-2005020546-A1,Pharmaceutical compositions comprising active vitamin D compounds ,"Novacea, Inc.","Barbara Laidlaw, James Swarbrick",2003-06-11,2004-06-10,2005-01-27,,https://patents.google.com/patent/US20050020546A1/en,https://patentimages.storage.googleapis.com/27/46/33/456ed467b666eb/US20050020546A1-20050127-D00001.png
US-2005009793-A1,Treatment of liver disease with active vitamin D compounds ,"Novacea, Inc.",John Curd,2002-11-21,2004-05-10,2005-01-13,,https://patents.google.com/patent/US20050009793A1/en,
US-2006178351-A1,Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents ,"Novacea, Inc.","John Curd, Martha Whitehouse, Jeffrey Cleland",2003-06-11,2005-12-12,2006-08-10,,https://patents.google.com/patent/US20060178351A1/en,
US-2007142339-A1,Prevention of arterial restenosis with active vitamin d compounds ,"Novacea, Inc.","Martha Whitehouse, Bradford Goodwin",2004-05-10,2005-05-10,2007-06-21,,https://patents.google.com/patent/US20070142339A1/en,
US-2005026877-A1,Pharmaceutical compositions comprising active vitamin D compounds ,"Novacea, Inc.","Andrew Chen, Jun Fan, Xi-Yun Yu, Martha Whitehouse, Barbara Laidlaw, James Swarbrick",2002-12-03,2004-05-10,2005-02-03,,https://patents.google.com/patent/US20050026877A1/en,https://patentimages.storage.googleapis.com/78/58/31/2279921267bdf7/US20050026877A1-20050203-D00001.png
US-2006177374-A1,Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments ,"Novacea, Inc.","John Curd, Jeffrey Cleland",2003-06-11,2005-12-12,2006-08-10,,https://patents.google.com/patent/US20060177374A1/en,
US-2007037779-A1,Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof ,"Curd John G, Henner William D, Beer Tomasz M, Goodwin Bradford S","John Curd, William Henner, Tomasz Beer, Bradford Goodwin",2005-01-05,2006-07-07,2007-02-15,,https://patents.google.com/patent/US20070037779A1/en,
US-8048872-B2,Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs ,Stat of Oregon Acting by and Through The Oregon State Board of Higher Education on Behalf of the University of Oregon,"John G. Curd, John F. W. Keana, Alshad S. Lalani, Paul B. Westberg, Bradford Goodwin, W. David Henner",2006-02-17,2008-04-29,2011-11-01,2011-11-01,https://patents.google.com/patent/US8048872B2/en,https://patentimages.storage.googleapis.com/dd/b7/83/468eb4ae0ac217/US08048872-20111101-D00001.png
US-2006189586-A1,Pharmaceutical compositions comprising active vitamin D compounds ,Cleland Jeffrey L,Jeffrey Cleland,2003-06-11,2005-12-12,2006-08-24,,https://patents.google.com/patent/US20060189586A1/en,https://patentimages.storage.googleapis.com/34/cd/0c/5ec8d5e91e2246/US20060189586A1-20060824-D00001.png
WO-2005117542-A2,Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments ,"Novacea, Inc.",John G. Curd,2004-05-10,2005-05-10,2005-12-15,,https://patents.google.com/patent/WO2005117542A2/en,
WO-2008115499-A1,Mannich base n-oxide drugs ,State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The University Of Oregon,"John G. Curd, John F. W. Keana, Alshad L. Lalani, Paul Westberg",2007-03-19,2008-03-19,2008-09-25,,https://patents.google.com/patent/WO2008115499A1/en,
US-2009163453-A1,Prevention and Treatment of Gastrointestinal and Bladder Disorders Associated with Chemotherapy or Radiation Therapy Using Active Vitamin D Compounds ,Novacea Inc.,"John G. Curd, Bradford S. Goodwin, Jeffrey L. Cleland",2005-09-26,2006-09-26,2009-06-25,,https://patents.google.com/patent/US20090163453A1/en,
US-2007117784-A1,Treatment of hyperproliferative diseases with anthraquinones ,"Novacea, Inc.","Jeffrey Cleland, Alvin Wong, Alshad Lalani",2005-03-04,2006-09-13,2007-05-24,,https://patents.google.com/patent/US20070117784A1/en,https://patentimages.storage.googleapis.com/8e/23/51/7e80925c7ad764/US20070117784A1-20070524-D00001.png
US-2008069814-A1,Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof ,"Novacea, Inc.","John Curd, William Henner, Tomasz Beer, Bradford Goodwin, Alshad Lalani",2005-01-05,2007-03-26,2008-03-20,,https://patents.google.com/patent/US20080069814A1/en,
WO-2007095389-A2,Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs ,"Novacea, Inc.","John G. Curd, John F. W. Keana, Alshad S. Lalani, Paul B. Westberg, Bradford S. Goodwin",2006-02-17,2007-02-20,2007-08-23,,https://patents.google.com/patent/WO2007095389A2/en,
CN-100386083-C,Methods of using vitamind compounds in the treatment of myelodysplastic syndromes ,诺瓦西股份有限公司,"J·G·柯德, M·J·怀特豪斯",2002-11-06,2003-11-06,2008-05-07,2008-05-07,https://patents.google.com/patent/CN100386083C/en,
WO-2008115531-A1,Prevention and treatment of infectious conditions with active vitamin d compounds or mimics thereof ,"Novacea, Inc.","Alshad S. Lalani, John G. Curd",2007-03-21,2008-03-20,2008-09-25,,https://patents.google.com/patent/WO2008115531A1/en,
WO-2007098089-A2,Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs ,"Novacea, Inc.","John G. Curd, John F.W. Keana, Alshad S. Lalani, Paul B. Westberg",2006-02-17,2007-02-20,2007-08-30,,https://patents.google.com/patent/WO2007098089A2/en,
US-2008305082-A1,"1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof ","Curd John G, Capizzi Robert L, Keana John F W","John G. Curd, Robert L. Capizzi, John F.W. Keana",2004-09-14,2005-09-14,2008-12-11,,https://patents.google.com/patent/US20080305082A1/en,
US-2009069276-A1,"Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof ","Novacea, Inc.","John G. Curd, Bradford S. Goodwin, Jeffrey L. Cleland",2005-04-22,2006-04-24,2009-03-12,,https://patents.google.com/patent/US20090069276A1/en,
WO-2005097128-A1,"1,4-bis-n-oxide azaanthracenediones and the use thereof ","Novacea, Inc.","John G. Curd, Robert L. Capizzi",2004-03-30,2005-03-30,2005-10-20,,https://patents.google.com/patent/WO2005097128A1/en,
WO-2007098090-A2,Treatment of hyperproliferative diseases with n-oxides of estrogen receptor modulators ,"Novacea, Inc.","John G. Curd, John F.W. Keana, Alshad S. Lalani, Paul B. Westberg",2006-02-17,2007-02-20,2007-08-30,,https://patents.google.com/patent/WO2007098090A2/en,
US-2007161808-A1,Process for the preparation of aq4n ,Kudos Pharmaceuticals Limited,"Ian Matthews, Ronald Scott, John Barry, Stephen Hughes, Ann Heslip",2004-02-13,2005-02-11,2007-07-12,,https://patents.google.com/patent/US20070161808A1/en,
WO-2008057363-A2,Use of vitamin d derivatives to enhance delivery of therapeutics and oxygen to tumors ,"Novacea, Inc.",John G. Curd,2006-11-01,2007-11-01,2008-05-15,,https://patents.google.com/patent/WO2008057363A2/en,
WO-2006096458-A2,Treatment of hyperproliferative diseases with anthraquinones ,"Novacea, Inc.","Jeffrey L. Cleland, Alvin Wong",2005-03-04,2006-03-03,2006-09-14,,https://patents.google.com/patent/WO2006096458A2/en,
WO-2008103320-A1,Methods of treating ophthalmic disorders with anthraquinones ,"Novacea, Inc.","John G. Curd, Alshad S. Lalani, Jeffrey L. Cleland",2007-02-16,2008-02-19,2008-08-28,,https://patents.google.com/patent/WO2008103320A1/en,
CN-1856251-A,Pharmaceutical compositions comprising active vitamin D compounds ,诺瓦西股份有限公司,"B·F·莱德劳, J·斯沃布里克",2003-06-11,2004-06-10,2006-11-01,,https://patents.google.com/patent/CN1856251A/en,
CN-101163483-A,"Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof ",诺瓦西股份有限公司,"B·S·古德温, J·G·柯德, J·L·克莱伦德",2005-04-22,2006-04-24,2008-04-16,,https://patents.google.com/patent/CN101163483A/en,
CN-1805688-A,Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments ,诺瓦西股份有限公司,J·G·柯德,2003-06-11,2004-06-10,2006-07-19,,https://patents.google.com/patent/CN1805688A/en,
WO-2008118150-A2,Nitric oxide synthase as a marker for treatment with bioreducible prodrugs ,"Novacea, Inc.","John G. Curd, Alshad S. Lalani",2006-11-10,2007-11-13,2008-10-02,,https://patents.google.com/patent/WO2008118150A2/en,
CN-1802349-A,Treatment of lung cancer with active vitamin D compounds in combination with other treatments ,诺瓦西股份有限公司,W·D·埃内,2003-06-11,2004-06-10,2006-07-12,,https://patents.google.com/patent/CN1802349A/en,
CN-1805750-A,Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents ,诺瓦西股份有限公司,"J·G·柯德, M·J·怀特豪斯",2003-06-11,2004-06-10,2006-07-19,,https://patents.google.com/patent/CN1805750A/en,
CN-101115487-A,Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof ,诺瓦西股份有限公司,"B·S·古德温, J·G·柯德, T·M·比尔, W·D·埃内",2005-01-05,2006-01-05,2008-01-30,,https://patents.google.com/patent/CN101115487A/en,
